ZCM
EBS icon

Zebra Capital Management’s Emergent Biosolutions EBS Stock Holding History

Zebra Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,250
Closed -$784K – 94
2022
Q2 		$784K Buy
25,250
+3,139
+14% +$107K 2.3% 6
2022
Q1 		$908K Buy
22,111
+1,520
+7% +$67K 2.09% 6
2021
Q4 		$895K Sell
20,591
-6,869
-25% -$311K 1.43% 16
2021
Q3 		$1.38M Buy
27,460
+8,545
+45% +$517K 1.67% 7
2021
Q2 		$1.19M Sell
18,915
-2,042
-10% -$131K 1.4% 15
2021
Q1 		$1.95M Buy
+20,957
New +$2.15M 2.14% 2
2020
Q3 		– Sell
-4,577
Closed -$362K – 196
2020
Q2 		$362K Buy
4,577
+7
+0.2% +$522 0.52% 65
2020
Q1 		$264K Sell
4,570
-327
-7% -$18.8K 0.43% 99
2019
Q4 		$264K Sell
4,897
-153
-3% -$8.3K 0.23% 182
2019
Q3 		$264K Buy
+5,050
New +$235K 0.29% 130
2018
Q4 		– Sell
-4,697
Closed -$309K – 392
2018
Q3 		$309K Buy
+4,697
New +$274K 0.14% 292
2018
Q2 		– Sell
-8,066
Closed -$425K – 336
2018
Q1 		$425K Buy
8,066
+1,050
+15% +$52.3K 0.15% 255
2017
Q4 		$326K Buy
7,016
+275
+4% +$11.6K 0.11% 282
2017
Q3 		$273K Buy
+6,741
New +$244K 0.09% 238

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Zebra Capital Management's EBS Position: Q3 2022 in Review

Zebra Capital Management sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 25,250 shares — an estimated $784K sold.

Zebra Capital Management first reported a position in EBS in Q3 2017 and held it in 14 quarters. The position peaked at $1.95M in Q1 2021. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • Zebra Capital Management reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • Zebra Capital Management sold 25,250 Emergent Biosolutions shares in Q3 2022, an estimated $784K.
  • Zebra Capital Management first reported a position in Emergent Biosolutions in Q3 2017 and held it in 14 quarters.
  • Zebra Capital Management's Emergent Biosolutions position peaked at $1.95M in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Zebra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.